The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes
- PMID: 18487476
- PMCID: PMC2494654
- DOI: 10.2337/dc08-0239
The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes
Abstract
Objective: The rising incidence of type 1 diabetes has been attributed to environment, implying a lesser role for genetic susceptibility. However, the rise could be accounted for by either more cases with classic high-risk genes or by cases with other risk genes. Separately, for any degree of genetic susceptibility, age at presentation may decrease in a permissive environment. To examine these possibilities, human leukocyte antigen (HLA) class II DRB1 genes known to confer risk for type 1 diabetes were analyzed in relation to year of birth and age at diagnosis over the last five decades.
Research design and methods: Caucasoid subjects (n = 462) diagnosed with type 1 diabetes before age 18 between 1950 and 2005 were DRB1 genotyped.
Results: Mean +/- SD age at diagnosis, 8.5 +/- 4.5 years, did not differ across decades. Recent diagnosis was associated with a lower proportion but unchanged incidence of the highest-risk DRB1 genotype DR3,4 (2000-2005, 28% vs. 1950-1969, 79%; P < 0.0001) and a higher proportion of lower-risk genotypes DR4,X and DR3,X (2000-2005, 48% vs. 1950-1969, 20%; P = 0.0002). The frequency of the DRX,X genotype was low (<or=3%) across decades. Recent birth was associated with a lower age at diagnosis for lower risk DR3,3 and DR4,4 (P < 0.0001) and DR4,X (P < 0.0001) and DR3,X (P = 0.015) genotypes but not for DR3,4.
Conclusions: The rising incidence and decreasing age at diagnosis of type 1 diabetes is accounted for by the impact of environment on children with lower-risk HLA class II genes, who previously would not have developed type 1 diabetes in childhood.
Figures
Similar articles
-
Genetic susceptibility factors of Type 1 diabetes in Asians.Diabetes Metab Res Rev. 2001 Jan-Feb;17(1):2-11. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr164>3.0.co;2-m. Diabetes Metab Res Rev. 2001. PMID: 11241886 Review.
-
Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.Diabetologia. 1999 May;42(5):608-16. doi: 10.1007/s001250051202. Diabetologia. 1999. PMID: 10333055
-
Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes.Diabetes Care. 2008 Jul;31(7):1392-6. doi: 10.2337/dc07-2210. Epub 2008 Mar 20. Diabetes Care. 2008. PMID: 18356404 Free PMC article.
-
Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.Diabetes Care. 1995 Nov;18(11):1483-6. doi: 10.2337/diacare.18.11.1483. Diabetes Care. 1995. PMID: 8722074
-
Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus.Am J Hum Genet. 1988 Dec;43(6):799-816. Am J Hum Genet. 1988. PMID: 3057885 Free PMC article. Review.
Cited by
-
Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.Hum Genomics. 2023 Nov 13;17(1):100. doi: 10.1186/s40246-023-00550-z. Hum Genomics. 2023. PMID: 37957681 Free PMC article.
-
The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness.Front Immunol. 2023 May 15;14:1158278. doi: 10.3389/fimmu.2023.1158278. eCollection 2023. Front Immunol. 2023. PMID: 37256143 Free PMC article. Review.
-
Multi-omic interactions in the gut of children at the onset of islet autoimmunity.Microbiome. 2022 Dec 16;10(1):230. doi: 10.1186/s40168-022-01425-6. Microbiome. 2022. PMID: 36527134 Free PMC article.
-
Epidemiology of Type 1 Diabetes.Curr Cardiol Rep. 2022 Oct;24(10):1455-1465. doi: 10.1007/s11886-022-01762-w. Epub 2022 Aug 17. Curr Cardiol Rep. 2022. PMID: 35976602 Review.
-
The missing heritability in type 1 diabetes.Diabetes Obes Metab. 2022 Oct;24(10):1901-1911. doi: 10.1111/dom.14777. Epub 2022 Jun 13. Diabetes Obes Metab. 2022. PMID: 35603907 Free PMC article. Review.
References
-
- Eisenbarth GS: Update in type 1 diabetes. J Clin Endocrinol Metab 92:2403–2407, 2007 - PubMed
-
- Eisenbarth GS: Type 1 Diabetes: Molecular, Cellular and Clinical Immunology. 2.5 ed. Eisenbarth GS, Ed. Denver, CO, The Barbara Davis Center for Childhood Diabetes, 2007
-
- Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AA, Ovington NR, Allen J, Adlem E, Leung HT, Wallace C, Howson JM, Guja C, Ionescu-Tîrgoviste C, Genetics of Type 1 Diabetes in Finland, Simmonds MJ, Heward JM, Gough SC, Dunger DB, Wicker LS, Clayton DG, the Wellcome Trust Case Control Consortium: Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864, 2007 - PMC - PubMed
-
- Gale EA: The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361, 2002 - PubMed
-
- The DIAMOND Project Group: Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 23:857–866, 2006 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
